Table 1.
Molecules | Function | SNPs | Consequence | Refs |
---|---|---|---|---|
VDR | receptor for 1,25(OH)2D | rs731236 | ↑ prostate cancer in Asians | [23] |
rs1544410 | ↑ colorectal cancer | [24] | ||
rs2228570 | ↑ prostate cancer | [25] | ||
↑ ovarian cancer in Caucasian | [26] | |||
↑ hepatocellular carcinoma | [27] | |||
rs757343 | ↑ breast cancer in Pakistani | [28] | ||
rs2238135 | ↑ breast cancer | [29] | ||
rs11168287 | ||||
rs2238136 | ||||
rs4237855 | ||||
GC/DBP | bind and transport 25(OH)D | rs2282679 | ↓ colorectal cancer patient survival | [36] |
rs7041 | ↓ non-small cell lung cancer | [38] | ||
rs4588 | ↓ survival of colorectal cancer patients treated with chemo/bevacizumab | [39] | ||
↑ survival of colorectal cancer patients treated with chemo/cetuximab | [39] | |||
CYP2R1 | hydroxylate vitamin D to 25(OH)D | rs12794714 | ↓ 25(OH)D levels ↑ ovarian cancer in European-ancestry |
[40] |
↑ colorectal cancer in African American | [41] | |||
CYP27B1 | Convert 25(OH)D to active 1,25(OH)2D | rs28934604 | ↓ enzyme activity ↓ 1,25(OH)2D levels in colon cancer cells |
[42] |
rs58915677 | ||||
rs13377933 | ||||
rs2229103 | ||||
rs3782130 | ↑ non-small cell lung cancer | [38] | ||
CYP24A1 | catabolize active 1,25(OH)2D to inactive metabolites | rs35051736 | ↓ enzyme activity ↑ 1,25(OH)2D levels in colon cancer cells |
[42] |
rsl6999131 | ||||
rs6022990 | ||||
rs6068812 | ||||
rs2585428 | ↓ pancreatic cancer in Caucasian | [43] | ||
rs4809960 | ↓ breast cancer in Caucasian | [43] | ||
rs6068816 | ↓ non-small cell lung carcinoma | [38] | ||
VDRE | vitamin D response element | rs9393682 | ↑ prostate cancer | [45] |
rs1378033 |
↑ = increases and ↓, = decreases consequence (i.e. cancer risk or progression).